Role of Sleep on Motor Learning in Parkinson's Disease and Healthy Older Adults
NCT ID: NCT04144283
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2019-11-15
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Triggering Motor Memory Consolidation in PD: Complex Practice of Fine Motor Tasks and Brain Activity During Learning
NCT04269590
Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease
NCT02288052
Learning Potential of Patients With Parkinson's Disease After Two Weeks of Targeted Touchscreen Training
NCT05696197
Motor Learning in Parkinson's Disease: Underlying Effective Connectivity and Influential Factors
NCT04269577
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease
NCT04620551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To test this, the investigators will employ a 'napping' protocol that accounts for circadian effects while allowing performance after diurnal sleep to be directly compared to that of a wake control group (King et al. 2017a). Consolidation will be defined as the change in Motor Sequence Learning (MSL) of finger tapping after a post-training period of either napping or wakefulness compared to the end of initial training. To further indicate robust consolidation, changes in performance will be assessed after a 24h retention period without further practice as well as during a dual-task as a measure of motor automaticity. A parallel group design will allow within group comparison (nap/wake) as well as between pwPD and controls. In a second study, the effects of TMR on consolidation will be compared across groups using a serial reaction time task (SRT).
The first objective (Experiment 1) is to determine whether a 2-hour nap improves the immediate consolidation, 24h retention and dual task interference of an MSL task as compared to a similar period of diurnal wakefulness in people with pwPD and healthy age-matched controls and whether the degree of performance change is different between these groups. Hypothesis 1: The investigators expect to find improved consolidation, 24h retention and reduced dual-task interference of MSL performance following a post-training nap compared to wakefulness in both groups. Possibly, improvements are less apparent in pwPD compared to controls due to their cortico-striatal impairments.
The second objective (Experiment 2) is to determine whether TMR improves immediate consolidation, 24h retention and dual task interference in pwPD and healthy older adults by comparing performance on two learned motor sequences before and after a 2-hour nap period, during which one of the two sequences is replayed using auditory TMR. Hypothesis 3: TMR during napping will improve immediate consolidation, 24h retention and dual task interference of the SRT in both healthy elderly and PD.
Participants first undergo screening, during which demographics, cognitive capacity and disease severity indexes (including dexterity tests) will be obtained prior to undergoing a diagnostic screening night with polysomnography (PSG) to assess for sleep disorder features. Participants will also complete a test battery on sleep quality scales and mood and wear an Actigraphy watch at home for at least five days and nights prior to the first experiment.
During experiment 1, participants learn the MSL by self-initiating a 5-element finger sequence that is presented on screen. After learning, participants will be equipped with PSG, which includes EEG. Based on blinded randomization, they will nap for 2 hours or lie on the bed but remain awake for a similar duration. The wake PSG will ensure that no participant in the wake group falls asleep. Participants will then enjoy a 30-45min break to counter sleep inertia effects, prior to being re-tested on the MSL (Retest 1). The next day, participants will be re-assessed on the MSL for 24h retention testing (Retest 2).
During experiment 2, similar procedures will be followed as described above except that participants will learn two new finger sequences that are auditory cued, by means of a serial reaction time task (SRT). For the SRT, participants view a row of empty squares presented in the middle of the screen and each time a square is highlighted the participant is instructed to tap the finger that is spatially associated to that square as quickly and accurately as possible, i.e. a serial reaction time task. The difference between the MSL task of experiment 1 and the SRT task of experiment 2 is therefore that during experiment 1 participants self-initiate a sequence that is explicitly shown to them, whereas in experiment 2 the sequence is cued. The order of sequence blocks during learning and retest as well as the sequence selected for TMR will be randomized across participants. Performance on both sequences will be re-assessed after the break, and again at 24h retention without auditory cues.
The MSL and SRT tests in both experiments will be preceded by a psychomotor vigilance test as an objective measure of the participants' vigilance on the day and include a single- and dual-task condition.
Power calculation:
Based on the findings by Terpening et al. (2013) and Dan et al. (2015), a minimum of 16 subjects per group (NAP, WAKE) will be required according to our power analysis based on the MSL-outcomes using β=0.20 and α=0.05 to detect a significant group difference. To account for potential dropouts, the recruitment target is set 20% higher to ensure adequate power in our final analysis. As such, a total of 40 PD patients and 40 healthy elderly controls will be recruited for experiment 1 (i.e. 20 in each NAP/WAKE group). The best sample estimation at this time for experiment 2 is based on previous TMR studies in younger adults also recruiting 16 subjects per nap/wake group (Antony et al. 2012). Therefore, we will target to recruit a total of 20 PD and 20 healthy elderly controls for Experiment 2, again accounting for 20% potential dropout.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NAP
The NAP group will undergo a post-learning 2-hour sleep opportunity in Experiment 1.
NAP
For experiment 1, the NAP group will undergo a post-learning 2-hour diurnal sleep opportunity (i.e. 'nap') without cues.
For experiment 2 the NAP+TMR group will undergo a post-learning 2-hour diurnal sleep opportunity (i.e. 'nap') with auditory TMR. The learning related sounds will be presented to participants at 140% of their minimal auditory detection threshold during stage 2 and stage 3 of NREM sleep.
WAKE
The WAKE group will undergo a post-learning 2-hour period of quiescent wakefulness in Experiment 1.
WAKE
For experiment 1, the WAKE group will undergo a post-learning 2-hour period of quiescent wakefulness without cues.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NAP
For experiment 1, the NAP group will undergo a post-learning 2-hour diurnal sleep opportunity (i.e. 'nap') without cues.
For experiment 2 the NAP+TMR group will undergo a post-learning 2-hour diurnal sleep opportunity (i.e. 'nap') with auditory TMR. The learning related sounds will be presented to participants at 140% of their minimal auditory detection threshold during stage 2 and stage 3 of NREM sleep.
WAKE
For experiment 1, the WAKE group will undergo a post-learning 2-hour period of quiescent wakefulness without cues.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can read and understand Dutch
* Age equal or greater than 40 years
* PwPD will have a clinical diagnosis of idiopathic Parkinson's disease made by a Neurologist
* Completed written informed consent approved by the assigned medical ethical committee
Exclusion Criteria
* Enrollment in an interventional trial for Parkinson's disease therapy
* Severe sleep apnea determined as an Apnea/Hypopnea index (AHI) \> 30 during the screening polysomnography (PSG)
* Cognitive impairment that could question the participant's ability to provide voluntary informed consent as determined by an Mini Mental State Examination score \<24
* Co-morbidities that would hamper interpretation of MSL or SRT learning, such as musculoskeletal abnormalities, as determined by a Neurologist or Physical Therapist.
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alice Nieuwboer
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alice Nieuwboer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Nieuwboer A, Rochester L, Muncks L, Swinnen SP. Motor learning in Parkinson's disease: limitations and potential for rehabilitation. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S53-8. doi: 10.1016/S1353-8020(09)70781-3.
King BR, Hoedlmoser K, Hirschauer F, Dolfen N, Albouy G. Sleeping on the motor engram: The multifaceted nature of sleep-related motor memory consolidation. Neurosci Biobehav Rev. 2017 Sep;80:1-22. doi: 10.1016/j.neubiorev.2017.04.026. Epub 2017 Apr 29.
King BR, Saucier P, Albouy G, Fogel SM, Rumpf JJ, Klann J, Buccino G, Binkofski F, Classen J, Karni A, Doyon J. Cerebral Activation During Initial Motor Learning Forecasts Subsequent Sleep-Facilitated Memory Consolidation in Older Adults. Cereb Cortex. 2017 Feb 1;27(2):1588-1601. doi: 10.1093/cercor/bhv347.
Terpening Z, Naismith S, Melehan K, Gittins C, Bolitho S, Lewis SJ. The contribution of nocturnal sleep to the consolidation of motor skill learning in healthy ageing and Parkinson's disease. J Sleep Res. 2013 Aug;22(4):398-405. doi: 10.1111/jsr.12028. Epub 2013 Feb 11.
Diekelmann S, Biggel S, Rasch B, Born J. Offline consolidation of memory varies with time in slow wave sleep and can be accelerated by cuing memory reactivations. Neurobiol Learn Mem. 2012 Sep;98(2):103-11. doi: 10.1016/j.nlm.2012.07.002. Epub 2012 Jul 10.
Micca L, Albouy G, King BR, D'Cruz N, Nieuwboer A, Vandenberghe W, Borzee P, Buyse B, Testelmans D, Nicolas J, Gilat M. The Effect of a Post-Learning Nap on Motor Memory Consolidation in People With Parkinson's Disease: A Randomised Controlled Trial. J Sleep Res. 2025 Sep 26:e70203. doi: 10.1111/jsr.70203. Online ahead of print.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
838576
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2019-J4121350-212854
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
S61792
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.